Dr. David Epstein Joins Aerie Pharmaceuticals Advisory Board

Aerie Pharmaceuticals has named David Epstein, MD, a board-certified ophthalmologist, as chairman of the company’s scientific advisory board.

Advertisement

Dr. Epstein is a co-founder of Aerie and chairman of Duke University’s ophthalmology department.

Aerie has also named Vicente Anido, Jr., PhD, an ophthalmology industry expert, as its chairman of the board.

More Articles on Ophthalmology:
InSite Vision Receives $15M in Royalties for Pink-Eye Treatment
IRIDEX, Peregrine Surgical Partner
Dr. Kenneth Pearlberg Joins Medifirst Solutions Advisory Board

Advertisement

Next Up in Ophthalmology

  • Southlake, Texas-based Retina Consultants of America has acquired Montana Retina Consultants, according to a Feb. 5 news release.  Bozeman-based Montana…

  • Vision Innovation Partners acquired Ophthalmic Associates of Alexandria (Va.), according to a Feb. 2 press release. Founded in 2010, Ophthalmic…

Advertisement

Comments are closed.